Cargando…

Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic Review

INTRODUCTION: Comorbid psychiatric conditions in children and adolescents with attention-deficit hyperactivity disorder (ADHD) occur frequently, complicate management, and are associated with substantial burden on patients and caregivers. Very few systematic reviews have assessed the efficacy and sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsujii, Noa, Usami, Masahide, Naya, Noriyuki, Tsuji, Toshinaga, Mishima, Hirokazu, Horie, Junko, Fujiwara, Masakazu, Iida, Junzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571469/ https://www.ncbi.nlm.nih.gov/pubmed/34089145 http://dx.doi.org/10.1007/s40120-021-00249-0

Ejemplares similares

Efficacy and safety of guanfacine extended‐release in Japanese adults with attention‐deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double‐blind, placebo‐controlled study
por: Naya, Noriyuki, et al.
Publicado: (2020)

The Burden of Undiagnosed Adults With Attention-Deficit/Hyperactivity Disorder Symptoms in Japan: A Cross-Sectional Study
por: Naya, Noriyuki, et al.
Publicado: (2021)

Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis
por: Sakai, Chika, et al.
Publicado: (2021)

The Burden of Attention-Deficit/Hyperactivity Disorder Traits in Adult Patients with Major Depressive Disorder in Japan
por: Kato, Masaki, et al.
Publicado: (2023)

Glucose and Prolactin Monitoring in Children and Adolescents Initiating Antipsychotic Therapy
por: Okumura, Yasuyuki, et al.
Publicado: (2018)

Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy
por: Kattimani, Shivanand, et al.
Publicado: (2011)

Attention deficit hyperactivity disorder and comorbidity: A review of literature
por: Gnanavel, Sundar, et al.
Publicado: (2019)

Attention deficit hyperactivity disorder and eating disorders: an overlooked comorbidity?
por: Soutullo Esperón, C.A., et al.
Publicado: (2022)

Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder
por: Jeon, Soo Min, et al.
Publicado: (2023)

Associations between the mismatch-negativity component and symptom severity in children and adolescents with attention deficit/hyperactivity disorder
por: Yamamuro, Kazuhiko, et al.
Publicado: (2016)

What Time Periods of the Day Are Concerning for Parents of Children with Attention Deficit Hyperactivity Disorder?
por: Usami, Masahide, et al.
Publicado: (2013)

Comorbidity of attention deficit hyperactivity disorder with personality disorders in homeless people
por: Salavera, Carlos, et al.
Publicado: (2014)

Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
por: Nakanishi, Yoko, et al.
Publicado: (2017)

Current use of attention-deficit hyperactivity disorder (ADHD) medications and clinical characteristics of child and adolescent psychiatric outpatients prescribed multiple ADHD medications in Japan
por: Sasaki, Yoshinori, et al.
Publicado: (2021)

Comorbidity and confounding factors in attention-deficit/hyperactivity disorder and sleep disorders in children
por: Jan, Ya-Wen, et al.
Publicado: (2011)

Impulsive Aggression as a Comorbidity of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
por: Saylor, Keith E., et al.
Publicado: (2016)

Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia
por: Golubchik, Pavel, et al.
Publicado: (2014)

Medical and Psychiatric Comorbidities in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Park, Kee Jeong, et al.
Publicado: (2017)

Risk factors for comorbid oppositional defiant disorder in attention-deficit/hyperactivity disorder
por: Noordermeer, Siri D. S., et al.
Publicado: (2017)

A case of dissociative identity disorder and attention deficit hyperactivity disorder comorbidity
por: Aydın, E.F., et al.
Publicado: (2022)

Neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. Case report
por: Del Sol Calderón, P., et al.
Publicado: (2022)

Comorbidity Matters: Social Visual Attention in a Comparative Study of Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder and Their Comorbidity
por: Ioannou, Chara, et al.
Publicado: (2020)

Long‐term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention‐deficit/hyperactivity disorder
por: Ichikawa, Hironobu, et al.
Publicado: (2019)

A Comparison of Comorbidity and Psychological Outcomes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Huh, Yoon, et al.
Publicado: (2011)

Adult Attention Deficit Hyperactivity Disorder and Violence in the Population of England: Does Comorbidity Matter?
por: González, Rafael A., et al.
Publicado: (2013)

Psychiatric comorbid patterns in adults with attention-deficit hyperactivity disorder: Treatment effect and subtypes
por: Tsai, Fang-Ju, et al.
Publicado: (2019)

Clinical features and suicidal behavior in major depression with comorbid attention-deficit hyperactivity disorder
por: Menon, Vikas, et al.
Publicado: (2020)

Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

A Case of Adult Attention Deficit Hyperactivity Disorder with Non-Organic Psychosis Comorbidity
por: Akyıldırım Çor, S., et al.
Publicado: (2022)

Beyond Attention-Deficit Hyperactivity Disorder: Exploring Psychiatric Comorbidities and Their Neuropsychological Consequences in Adults
por: Roh, Hyun Jae, et al.
Publicado: (2023)

Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Bahk, W.-M., et al.
Publicado: (2023)

Impulsive choice in individuals with comorbid amphetamine use disorder and attention deficit-hyperactivity disorder
por: Brynte, Christoffer, et al.
Publicado: (2023)

Healthcare utilisation in the United Arab Emirates for children with attention-deficit hyperactivity disorder and comorbidities
por: Almai, Ahmad M., et al.
Publicado: (2023)

The impact of comorbid anxiety on quantitative EEG heterogeneity in children with attention-deficit/hyperactivity disorder
por: Jang, Changwon, et al.
Publicado: (2023)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
por: Clemow, David B, et al.
Publicado: (2017)

Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
por: Ichikawa, Hironobu, et al.
Publicado: (2020)

Trajectories of Healthcare Utilization Among Children and Adolescents With Autism Spectrum Disorder and/or Attention-Deficit/Hyperactivity Disorder in Japan
por: Aoki, Ai, et al.
Publicado: (2022)

A 4-Year Follow-Up Study of Attention-Deficit Hyperactivity Symptoms, Comorbidities, and Psychostimulant Use in a Brazilian Sample of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Palma, Sonia M. M., et al.
Publicado: (2015)

Working Conditions, Work Productivity, Quality of Life, and Depressive Symptoms in Undiagnosed Adults with and without Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms During the COVID-19 Pandemic
por: Nakai, Toru, et al.
Publicado: (2022)

Psychiatric Comorbidity in Korean Children and Adolescents with Attention-Deficit Hyperactivity Disorder: Psychopathology According to Subtype
por: Byun, Heejung, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_aibsvbq4ch4me62gjg6muu0p37